|
KARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.86589640907664E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.6988000136401E-09 |
| Normal-vs-Stage2 |
2.423300E-03 |
| Normal-vs-Stage3 |
3.581500E-04 |
| Normal-vs-Stage4 |
1.368490E-02 |
| Stage1-vs-Stage2 |
7.525000E-01 |
| Stage1-vs-Stage3 |
3.921200E-01 |
| Stage1-vs-Stage4 |
2.796200E-01 |
| Stage2-vs-Stage3 |
3.678000E-01 |
| Stage2-vs-Stage4 |
2.162000E-01 |
| Stage3-vs-Stage4 |
6.711200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74249503714918E-11 |
| Normal-vs-AfricanAmerican |
7.84200000000235E-05 |
| Normal-vs-Asian |
1.251200E-01 |
| Caucasian-vs-AfricanAmerican |
2.278600E-01 |
| Caucasian-vs-Asian |
7.185800E-01 |
| AfricanAmerican-vs-Asian |
4.382400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62930002822748E-10 |
| Normal-vs-Female |
7.15469999912344E-08 |
| Male-vs-Female |
7.369600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.042600E-03 |
| Normal-vs-Extreme_Weight |
4.0370999987438E-08 |
| Normal-vs-Obese |
4.69149999959839E-08 |
| Normal-vs-Extreme_Obese |
2.509400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.342160E-01 |
| Normal_Weight-vs-Obese |
6.979900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.859800E-01 |
| Extreme_Weight-vs-Obese |
6.173600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.303400E-01 |
| Obese-vs-Extreme_Obese |
6.159000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.098800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.59660004608975E-09 |
| Normal-vs-Age(61-80Yrs) |
2.51069998125075E-09 |
| Normal-vs-Age(81-100Yrs) |
6.919600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.962200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.801400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.473800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.374200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.054200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.927200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12719833467168E-11 |
| Normal-VS-Type2 PRCC |
6.357600E-04 |
| Normal-VS-KIRP CIMP |
8.163300E-03 |
| Normal-VS-Unclassified PRCC |
4.33930000000027E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.259600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.907600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.160000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.759580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.572000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.779600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.798300E-03 |
| Normal-vs-N1 |
1.78728999999933E-05 |
| Normal-vs-N2 |
8.128400E-01 |
| N0-vs-N1 |
1.082590E-01 |
| N0-vs-N2 |
4.767600E-01 |
| N1-vs-N2 |
7.580400E-02 |
|
|
